List of Excipients in API hydrocortisone acetate and pramoxine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing hydrocortisone acetate and pramoxine hydrochloride
Detailed excipient profiles for hydrocortisone acetate and pramoxine hydrochloride
Excipient focus: CETYL ALCOHOL
hydrocortisone acetate and pramoxine hydrochloride drug variants containing CETYL ALCOHOL
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIISOPROPYL ADIPATE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing DIISOPROPYL ADIPATE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing DIISOPROPYL ADIPATE
Excipient focus: DIMETHICONE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing DIMETHICONE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing DIMETHICONE
Excipient focus: GLYCERIN
hydrocortisone acetate and pramoxine hydrochloride drug variants containing GLYCERIN
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing GLYCERIN
Excipient focus: HYDROGENATED COCONUT OIL
hydrocortisone acetate and pramoxine hydrochloride drug variants containing HYDROGENATED COCONUT OIL
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing HYDROGENATED COCONUT OIL
Excipient focus: ISOBUTANE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing ISOBUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing ISOBUTANE
Excipient focus: ISOPROPYL PALMITATE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing ISOPROPYL PALMITATE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing ISOPROPYL PALMITATE
Excipient focus: LANOLIN
hydrocortisone acetate and pramoxine hydrochloride drug variants containing LANOLIN
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing LANOLIN
Excipient focus: METHYLPARABEN
hydrocortisone acetate and pramoxine hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: PETROLATUM
hydrocortisone acetate and pramoxine hydrochloride drug variants containing PETROLATUM
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing PETROLATUM
Excipient focus: POLYOXYL 40 STEARATE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing POLYOXYL 40 STEARATE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing POTASSIUM SORBATE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing POVIDONE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing POVIDONE
Excipient focus: PROPANE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing PROPANE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing PROPANE
Excipient focus: PROPYLENE GLYCOL
hydrocortisone acetate and pramoxine hydrochloride drug variants containing PROPYLENE GLYCOL
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
hydrocortisone acetate and pramoxine hydrochloride drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SORBIC ACID
hydrocortisone acetate and pramoxine hydrochloride drug variants containing SORBIC ACID
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN SESQUIOLEATE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing SORBITAN SESQUIOLEATE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing SORBITAN SESQUIOLEATE
Excipient focus: STEARIC ACID
hydrocortisone acetate and pramoxine hydrochloride drug variants containing STEARIC ACID
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
hydrocortisone acetate and pramoxine hydrochloride drug variants containing STEARYL ALCOHOL
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing STEARYL ALCOHOL
Excipient focus: TRIETHANOLAMINE LAURYL SULFATE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing TRIETHANOLAMINE LAURYL SULFATE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing TRIETHANOLAMINE LAURYL SULFATE
Excipient focus: TROLAMINE
hydrocortisone acetate and pramoxine hydrochloride drug variants containing TROLAMINE
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing TROLAMINE
Excipient focus: WATER
hydrocortisone acetate and pramoxine hydrochloride drug variants containing WATER
hydrocortisone acetate and pramoxine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links